ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector CellsDaniel W. Lee, Sattva S. Neelapu, Marcelo C. Pasquini et al.|Transplantation and Cellular Therapy|2018Cited by 3.6k
Updated Analysis of the Efficacy and Safety of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed/Refractory (r/r) Acute Lymphoblastic LeukemiaStephan A. Grupp, Hidefumi Hiramatsu, Shannon L. Maude et al.|Blood|2018Cited by 94
An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftmentLamis Eldjerou, Malcolm A.S. Moore, Sonali Chaudhury et al.|Blood|2010Cited by 52
Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant ResearchMichael J. Burke, Carrie L. Kitko, Michael R. Verneris et al.|Transplantation and Cellular Therapy|2015Cited by 37
Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Updated Analysis of the ELIANA Clinical TrialStephan A. Grupp, Hidefumi Hiramatsu, Shannon L. Maude et al.|Transplantation and Cellular Therapy|2019Cited by 17